Triplitt C - Search Results

1

Exenatide improves both hepatic and adipose tissue insulin resistance: A dynamic positron emission tomography study.

Gastaldelli A, Gaggini M, Daniele G, Ciociaro D, Cersosimo E, Tripathy D, Triplitt C, Fox P, Musi N, DeFronzo R, Iozzo P. Gastaldelli A, et al. Among authors: triplitt c. Hepatology. 2016 Dec;64(6):2028-2037. doi: 10.1002/hep.28827. Hepatology. 2016. PMID: 27639082 Clinical Trial.

2

Effect of rosiglitazone on glucose and non-esterified fatty acid metabolism in Type II diabetic patients.

Miyazaki Y, Glass L, Triplitt C, Matsuda M, Cusi K, Mahankali A, Mahankali S, Mandarino LJ, DeFronzo RA. Miyazaki Y, et al. Among authors: triplitt c. Diabetologia. 2001 Dec;44(12):2210-9. doi: 10.1007/s001250100031. Diabetologia. 2001. PMID: 11793023 Clinical Trial.

3

Abdominal fat distribution and peripheral and hepatic insulin resistance in type 2 diabetes mellitus.

Miyazaki Y, Glass L, Triplitt C, Wajcberg E, Mandarino LJ, DeFronzo RA. Miyazaki Y, et al. Among authors: triplitt c. Am J Physiol Endocrinol Metab. 2002 Dec;283(6):E1135-43. doi: 10.1152/ajpendo.0327.2001. Am J Physiol Endocrinol Metab. 2002. PMID: 12424102 Free article. Clinical Trial.

4

Dose-response effect of a single administration of oral hexyl-insulin monoconjugate 2 in healthy nondiabetic subjects.

Wajcberg E, Miyazaki Y, Triplitt C, Cersosimo E, DeFronzo RA. Wajcberg E, et al. Among authors: triplitt c. Diabetes Care. 2004 Dec;27(12):2868-73. doi: 10.2337/diacare.27.12.2868. Diabetes Care. 2004. PMID: 15562199 Clinical Trial.

5

Exenatide: from the Gila monster to the pharmacy.

Triplitt C, Chiquette E. Triplitt C, et al. J Am Pharm Assoc (2003). 2006 Jan-Feb;46(1):44-52; quiz 53-5. doi: 10.1331/154434506775268698. J Am Pharm Assoc (2003). 2006. PMID: 16529340 Review.

6

Comparison of glargine insulin versus rosiglitazone addition in poorly controlled type 2 diabetic patients on metformin plus sulfonylurea.

Triplitt C, Glass L, Miyazaki Y, Wajcberg E, Gastaldelli A, De Filippis E, Cersosimo E, DeFronzo RA. Triplitt C, et al. Diabetes Care. 2006 Nov;29(11):2371-7. doi: 10.2337/dc06-0564. Diabetes Care. 2006. PMID: 17065670 Clinical Trial.

7

First approved inhaled insulin therapy for diabetes mellitus.

Jani R, Triplitt C, Reasner C, Defronzo RA. Jani R, et al. Among authors: triplitt c. Expert Opin Drug Deliv. 2007 Jan;4(1):63-76. doi: 10.1517/17425247.4.1.63. Expert Opin Drug Deliv. 2007. PMID: 17184163 Review.

8

Rosiglitazone decreases albuminuria in type 2 diabetic patients.

Miyazaki Y, Cersosimo E, Triplitt C, DeFronzo RA. Miyazaki Y, et al. Among authors: triplitt c. Kidney Int. 2007 Dec;72(11):1367-73. doi: 10.1038/sj.ki.5002516. Epub 2007 Sep 5. Kidney Int. 2007. PMID: 17805239 Free article. Clinical Trial.

9

Addition of pioglitazone and ramipril to intensive insulin therapy in type 2 diabetic patients improves vascular dysfunction by different mechanisms.

Fernandez M, Triplitt C, Wajcberg E, Sriwijilkamol AA, Musi N, Cusi K, DeFronzo R, Cersosimo E. Fernandez M, et al. Among authors: triplitt c. Diabetes Care. 2008 Jan;31(1):121-7. doi: 10.2337/dc07-0711. Epub 2007 Oct 1. Diabetes Care. 2008. PMID: 17909084 Clinical Trial.

10

Physiological and molecular determinants of insulin action in the baboon.

Chavez AO, Lopez-Alvarenga JC, Tejero ME, Triplitt C, Bastarrachea RA, Sriwijitkamol A, Tantiwong P, Voruganti VS, Musi N, Comuzzie AG, DeFronzo RA, Folli F. Chavez AO, et al. Among authors: triplitt c. Diabetes. 2008 Apr;57(4):899-908. doi: 10.2337/db07-0790. Epub 2008 Jan 3. Diabetes. 2008. PMID: 18174524

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

94 results

Search Page